These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 12391608)
1. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. Kubo T; Nishimura S; Kumagae Y; Kaneko I J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608 [TBL] [Abstract][Full Text] [Related]
2. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Kaneko I; Morimoto K; Kubo T Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586 [TBL] [Abstract][Full Text] [Related]
3. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions. Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007 [TBL] [Abstract][Full Text] [Related]
6. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Page G; Rioux Bilan A; Ingrand S; Lafay-Chebassier C; Pain S; Perault Pochat MC; Bouras C; Bayer T; Hugon J Neuroscience; 2006; 139(4):1343-54. PubMed ID: 16581193 [TBL] [Abstract][Full Text] [Related]
7. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment. Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898 [TBL] [Abstract][Full Text] [Related]
8. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Stege GJ; Renkawek K; Overkamp PS; Verschuure P; van Rijk AF; Reijnen-Aalbers A; Boelens WC; Bosman GJ; de Jong WW Biochem Biophys Res Commun; 1999 Aug; 262(1):152-6. PubMed ID: 10448084 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
10. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity. Caraci F; Chisari M; Frasca G; Canonico PL; Battaglia A; Calafiore M; Battaglia G; Bosco P; Nicoletti F; Copani A; Sortino MA Brain Res; 2005 Jun; 1047(1):30-7. PubMed ID: 15882840 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
12. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119 [TBL] [Abstract][Full Text] [Related]
13. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. Yamin G J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166 [TBL] [Abstract][Full Text] [Related]
14. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089 [TBL] [Abstract][Full Text] [Related]
15. Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Morimoto K; Yoshimi K; Tonohiro T; Yamada N; Oda T; Kaneko I Neuroscience; 1998 May; 84(2):479-87. PubMed ID: 9539218 [TBL] [Abstract][Full Text] [Related]
16. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Tomiyama T; Asano S; Suwa Y; Morita T; Kataoka K; Mori H; Endo N Biochem Biophys Res Commun; 1994 Oct; 204(1):76-83. PubMed ID: 7945395 [TBL] [Abstract][Full Text] [Related]
17. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Patil S; Sheng L; Masserang A; Chan C Neurosci Lett; 2006 Oct; 406(1-2):55-9. PubMed ID: 16904262 [TBL] [Abstract][Full Text] [Related]
18. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104 [TBL] [Abstract][Full Text] [Related]